Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 2,309 shares at $319.03 ($746K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $746k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $319.03 | 106 | $34K | 4.5% |
| 2 | $320.01 | 102 | $33K | 4.4% |
| 3 | $320.81 | 215 | $69K | 9.2% |
| 4 | $321.82 | 289 | $93K | 12.5% |
| 5 | $323.01 | 350 | $113K | 15.2% |
| 6 | $323.84 | 767 |
| $248K |
| 33.3% |
| 7 | $324.88 | 272 | $88K | 11.8% |
| 8 | $325.67 | 208 | $68K | 9.1% |
| Total | $323.08 avg | 2,309 | $746K | 100% |
| Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |
| ALNY | SELL | 2025-09-02 | $3.1M | — | Filing → |